Dominguez-Casas, L.Calvo-Rio, V.Beltran, E.S-Burson, J.Mesquida, M.Adan, A.Hernandez, M.H-Grafella, M.V-Pascual, E.M-Costa, L.Sellas, A.Cordero-Coma, M.Diaz-Llopis, M.Gallego, R.Salom, D.G-Serrano, J.Ortego, N.Herreras, J.G-Aparicio, A.Maiz, O.Blanco, A.Torre, I.Diaz-Valle, D.Pato, E.Aurrecoechea, E.Caracuel, M.Gamero, F.Minguez, E.Carrasco, C.Olive, A.Vazquez, J.R-Moreno, O.Manero, J.Munoz, S.Gandia, M.Rubio-Romero, E.Toyos-SMiera, F.Lopez-Longo, F.Nolla, J.Revenga, M.Vegas-Revenga, N.Fernandez-Diaz, C.Demetrio-Pablo, R.Gonzalez-Gay, M.Blanco, R.2025-01-072025-01-072017-06-010003-4967https://hdl.handle.net/10668/25291enSHORT AND LONG-TERM FOLLOW-UP WITH ADALIMUMAD IN REFRACTORY UVEITIS ASSOCIATED TO BEHCET'S DISEASE. MULTICENTER STUDY OF 74 PATIENTSconference outputopen access10.1136/annrheumdis-2017-eular.35771468-2060https://ard.bmj.com/content/annrheumdis/76/Suppl_2/326.2.full.pdf413181401009